Form 424B1 - Prospectus [Rule 424(b)(1)]:
SEC Accession No. 0001493152-21-031510
Filing Date
2021-12-15
Accepted
2021-12-15 11:25:53
Documents
21

Document Format Files

Seq Description Document Type Size
1 form424b1.htm 424B1 2794166
2 logo_001.jpg GRAPHIC 34963
3 chart_001.jpg GRAPHIC 95528
4 chart_002.jpg GRAPHIC 95528
5 pg80-149_002.jpg GRAPHIC 265534
6 pg80-149_003.jpg GRAPHIC 141201
7 pg80-147_004.jpg GRAPHIC 106448
8 pg80-147_005.jpg GRAPHIC 58324
9 pg80-149_006.jpg GRAPHIC 115539
10 pg80-147_007.jpg GRAPHIC 84455
11 pg80-149_008.jpg GRAPHIC 122530
12 pg80-149_009.jpg GRAPHIC 133722
13 pg80-149_010.jpg GRAPHIC 77161
14 pg80-149_011.jpg GRAPHIC 44556
15 drsaa_004.jpg GRAPHIC 142377
16 drsa_011.jpg GRAPHIC 38475
17 drsa_012.jpg GRAPHIC 74389
18 pg80-149_014.jpg GRAPHIC 152636
19 drsa_003.jpg GRAPHIC 84429
20 pg80-149_016.jpg GRAPHIC 91291
21 fin_001.jpg GRAPHIC 5935
  Complete submission text file 0001493152-21-031510.txt   5504078
Mailing Address OLGETTINA, NO. 58 MILAN L6 20132
Business Address OLGETTINA, NO. 58 MILAN L6 20132 39-02-2643-6639
Genenta Science S.p.A. (Filer) CIK: 0001838716 (see all company filings)

EIN.: 000000000 | State of Incorp.: L6
Type: 424B1 | Act: 33 | File No.: 333-260923 | Film No.: 211493505
SIC: 2836 Biological Products, (No Diagnostic Substances)